COLOSIMO, CARLO
 Distribuzione geografica
Continente #
NA - Nord America 417
Continente sconosciuto - Info sul continente non disponibili 295
AS - Asia 27
EU - Europa 22
SA - Sud America 1
Totale 762
Nazione #
US - Stati Uniti d'America 363
IT - Italia 22
CA - Canada 18
CN - Cina 10
JM - Giamaica 9
SG - Singapore 9
BD - Bangladesh 6
CR - Costa Rica 4
BB - Barbados 3
GT - Guatemala 3
HN - Honduras 3
BZ - Belize 2
HK - Hong Kong 2
TT - Trinidad e Tobago 2
AW - Aruba 1
BM - Bermuda 1
BS - Bahamas 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
GD - Grenada 1
KY - Cayman, isole 1
LC - Santa Lucia 1
SV - El Salvador 1
SX - ???statistics.table.value.countryCode.SX??? 1
TC - Turks e Caicos 1
VE - Venezuela 1
VG - Isole Vergini Britanniche 1
Totale 469
Città #
San Jose 113
Santa Clara 16
Ashburn 13
Beijing 10
Dallas 9
Singapore 9
Los Angeles 7
Chicago 6
Miami 6
Brooklyn 5
Kingston 4
Philadelphia 4
Seattle 4
Abbeville 3
Boston 3
Bridgetown 3
Charlotte 3
Lexington 3
Montreal 3
Naples 3
New Orleans 3
North Kansas City 3
Queens 3
San José 3
Ajax 2
Atlanta 2
Chattanooga 2
Cincinnati 2
Denver 2
Galt 2
Guatemala City 2
Hong Kong 2
Jacksonville 2
Jersey City 2
Louisville 2
Manassas 2
Milan 2
Milwaukee 2
Sacramento 2
San Antonio 2
Secaucus 2
Tegucigalpa 2
The Bronx 2
Washington 2
Winston-Salem 2
Aberdeen 1
Afragola 1
Agerola 1
Alajuela 1
Aliso Viejo 1
Allentown 1
Augusta 1
Baltimore 1
Banning 1
Bari 1
Baton Rouge 1
Bellflower 1
Belmopan 1
Bergenfield 1
Binbrook 1
Bismarck 1
Bluffton 1
Bologna 1
Broken Bow 1
Brookfield 1
Browns Mills 1
Buffalo 1
Cagliari 1
Cambridge 1
Carol Stream 1
Carson 1
Cartersville 1
Castries 1
Chaguanas 1
Chickasha 1
Corner Brook 1
Corpus Christi 1
Couva 1
Cromwell 1
Davie 1
Dearborn 1
Des Plaines 1
Detroit 1
Duncanville 1
Dundalk 1
Erie 1
Fayetteville 1
Federal Way 1
Flat Lick 1
Florence 1
Fort Lauderdale 1
Fort Myers 1
Fresno 1
Gardnerville 1
Gatineau 1
George Town 1
Gloucester 1
Gloucester City 1
Gonzales 1
Hamilton 1
Totale 336
Nome #
Dystonia in atypical parkinsonian disorders 16
Factors influencing secondary non-response to botulinum toxin type A injections in cervical dystonia 8
Non-motor symptoms (NMS)in parkinsonism: preliminary results of the PRIAMO(Parkinson and non-motor symptoms)study 7
Yawning in Parkinson's disease 6
Lewy body cortical involvement may not always predict dementia in Parkinson's disease 6
Survey of practices employed by neurologists for the definition and management of secondary non-response to botulinum toxin in cervical dystonia 6
Role of cardiac adrenergic function assessed by 123-I-MIBG in newly diagnosed parkinsonism patients 6
Hyperkinetic movement disorders emergencies 6
Lewy body cortical involvement may not always predict dementia in Parkinson's disease 6
Early distinction of Parkinson-variant multiple system atrophy from Parkinson's disease 6
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy 5
Nonmotor symptoms in adult-onset focal dystonia: psychiatric abnormalities 5
A comparative study of primary and secondary hemifacial spasm 5
ALPHA-INTERFERON THERAPY IN A CASE OF PROBABLE PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 5
Codon 200 mutation in a new family of Chilean origin with Creutzfeldt-Jakob disease 5
Ixcellence Network®: an international educational network to improve current practice in the management of cervical dystonia or spastic paresis by botulinum toxin injection 5
Motor fluctuations in Parkinson's disease: pathophysiology and treatment 5
Epidemiology of multiple system atrophy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms 5
Plasma Screening for Progranulin Mutations in Patients with Progressive Supranuclear Palsy and Corticobasal Syndromes 5
Handbook of Atypical Parkinsonism 5
Which model of stroke unit is better for stroke patient management 5
Tha tau gene in progressive supranuclear palsy: exclusion of mutations in coding exons and exon 10 splice sites, and identification of a new intronic variant of the disease-associated H1 haplotype in italian cases 5
Pisa syndrome in a patient with multiple system atrophy 5
Accuracy of clinical diagnosis of progressive supranuclear palsy 5
Cognitive disorders and mood disorders in Parkinson's disease 5
Fifty years of progressive supranuclear palsy 5
Non-motor symptoms in atypical parkinsonism: results from the PRIAMO study 5
A case of atypical adult-onset tic disorder 5
Which model of stroke unit is better for stroke patient management? 4
The unified Multiple System Atrophy Rating Scale: Intrarater reliability 4
Health-related quality of life in multiple system atrophy 4
3RD INTERNATIONAL-CONFERENCE ON DYSKINESIAS - (ORLANDO, NOVEMBER 7-12 1994) 4
Voluntary, spontaneous and reflex blinking in patients with clinically probable progressive supranuclear palsy 4
Clinical diagnosis of multiple system atrophy: level of agreement between Quinn's criteria and the consensus conference guidelines 4
Levodopa: back to the future 4
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria 4
Sad and happy facial emotion recognition impairment in progressive supranuclear palsy in comparison with Parkinson's disease 4
NATURAL AGING IS ASSOCIATED WITH SPECIFIC LESIONS OF CENTRAL NERVOUS-SYSTEM CHOLINERGIC NEURONS 4
A Transverse and Longitudinal MR Imaging Voxel-Based Morphometry Study in Patients with Primary Cervical Dystonia 4
The PRIAMO Study: a multicentric assessment of non-motor symptoms and their impact on quality of life in Parkinson's disease 4
MULTIPLE SYSTEM ATROPHY PRESENTING AS PARKINSONISM - CLINICAL-FEATURES AND DIAGNOSTIC-CRITERIA 4
Secondary non response (SNR) to botulinum toxins type A (BoNT-A) in cervical dystonia (CD) patients: Definition and therapeutic strategies results from an international survey 4
Lack of association between progressive supranuclear palsy and arterial hypertension: A clinico-pathological study 4
Coffee drinking and cigarette smoking in primary adult-onset dystonia: a multicenter case-control investigation 4
Zonisamide for essential tremor 4
A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism 4
Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS) 4
New developments in the field of basal ganglia diseases 4
Physical therapy in Parkinson's disease: Critical considerations 4
Parasympathetic dysfunction predicts loss of nocturnal blood pressure fall in Parkinson’s Disease and Multiple System Atrophy 4
Smoking habits in multiple system atrophy and progressive supranuclear palsy. European Study Group on Atypical Parkinsonisms 4
Craniocervical dystonia: clinical and pathophysiological features 4
Excessive Daytime Sleepiness in Multiple System Atrophy (SLEEMSA Study) 4
Early distinction of Parkinsonian-variant multiple system atrophy from Parkinson’s disease 4
Yawning in Parkinson's disease 4
Supine hypertension in Parkinson’s disease and multiple system atrophy 4
Non-motor symptoms in atypical parkinsonism. The PRIAMO study 4
Psychosis associated to Parkinson's disease in the early stages: relevance of cognitive decline and depression 4
Motor response to acute dopaminergic challenge with apomorphine and levodopa in Parkinson's disease: Implications for the pathogenesis of the on-off phenomenon 4
The PRIAMO study: background, methods and recruitment 4
Diffusion tensor imaging in primary cervical dystonia 4
Nonmotor presentations of multiple system atrophy 4
Management of multiple system atrophy: state of the art 4
Abnormal cortical plasticity in primary motor cortex in progressive supranuclear palsy 4
Defining spasticity: a new approach considering current movement disorders terminology and botulinum toxin therapy 4
Parkinsonism due to ephedrone neurotoxicity: a case report 4
Treatment Strategies in Early Parkinson's Disease 4
SOME SPECIFIC CLINICAL-FEATURES DIFFERENTIATE MULTIPLE SYSTEM ATROPHY (STRIATONIGRAL VARIETY) FROM PARKINSONS-DISEASE 4
Psychiatric disorders in adult-onset focal dystonia: a case-control study 4
No association between essential tremor and migraine: A case-control study 4
EFNS/MDS-ES recommendations for the diagnosis of Parkinson's disease 4
The symptomatic treatment of multiple system atrophy 4
Dopamine transporter immunoreactivity in peripheral blood lymphocytes in Parkinson's disease 4
Hedonistic homeostatic dysregulation in Parkinson's disease: a short screening questionnaire 4
Dyskinesias and motor symptoms onset in Parkinson disease 4
Aggiornamento sulla malattia di Hallervorden-Spatz 4
Long-term assessment of the risk of spread in primary late-onset focal dystonia 4
Excessive Daytime Sleepiness in Multiple System Atrophy (SLEEMSA Study) 4
Preface - Special issue: Multiple system atrophy 3
'Abnormal' DaTSCAN in a case of unilateral hand tremor associated with caudate infarct 3
The accuracy of clinical diagnosis of progressive supranuclear palsy: Applications with "grey"cases and true negative cases 3
Psychogenic tremor in Parkinson's disease 3
Camptocormia may be myopathic or dystonic 3
Primary motor cortex LTP/LTD-like plasticity in probable corticobasal syndrome 3
Alprazolam for essential tremor 3
TORTICOLLIS AFTER ELECTROCUTION 3
Abnormal salivary total and oligomeric alpha-synuclein in Parkinson's disease 3
Direct genetic evidence for involvement of tau in progressive supranuclear palsy. European Study Group on Atypical Parkinsonism Consortium 3
Selective impairment of action-verb naming and comprehension in progressive supranuclear palsy 3
BOXER DISQUALIFIED FOR TAKING SELEGILINE 3
Injection of the Iliopsoas Muscle with Botulinum Toxin in Camptocormia 3
For postprandial hypotension (vol 3, pg 93, 2004) 3
Diagnostic criteria for multiple system atrophy and progressive supranuclear palsy 3
A comparative study of primary and secondary hemifacial spasm 3
How Do I Examine Blepharospasm? 3
Acute challenge with apomorphine and levodopa in parkinsonism 3
A new score predicting intraprocedural risk in patients undergoing CT-guided percutaneous needle pulmonary biopsy (CATH-score) 3
Handbook of Neurological Therapy 3
FATIGUE IN MS IS ASSOCIATED WITH SPECIFIC CLINICAL-FEATURES 3
A Further Case of Nicotine Sensitivity in Multiple System Atrophy 3
Totale 429
Categoria #
all - tutte 16.235
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.235


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2026/2027762 310 113 339 0 0 0 0 0 0 0 0 0
Totale 762